Tokyo, Nov. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059674) titled 'A study on the significance of Type 2 inflammation in chronic obstructive pulmonary disease (COPD) using data from the TRACK study' on Nov. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Saga University
Condition:
Condition - COPD
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to determine the clinical significance of type 2 inflammatory phenotype stratification in Japanese COPD patients and to verify whether this phenotype stratification can serve as a selection criterion for anti-inflammatory treatment.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - COPD patients participating in the TRACK study
Key exclusion criteria - none
Target Size - 572
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 06 Month 01 Day
Date of IRB - 2025 Year 08 Month 25 Day
Anticipated trial start date - 2025 Year 10 Month 31 Day
Last follow-up date - 2026 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068260
Disclaimer: Curated by HT Syndication.
